- Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma
[作者:Kawasaki, Y; Tamamoto, A; Takagi-Kimura, M; Maeyama, Y; Yamaoka, N; Terada, N; Okamura, H; Kasahara, N; Kubo, S,期刊:Cancer gene therapy, 页码:571-578 , 文章类型: Article,,卷期:2011年18-8]
- Replication-competent retrovirus (RCR) vectors have been shown to achieve significantly enhanced tumor transduction efficiency and therapeutic efficacy in various cancer models. In the present study, we investigated RCR ...
- Competitive electroporation formulation for cell therapy
[作者:Flanagan, M; Gimble, JM; Yu, G; Wu, X; Xia, X; Hu, J; Yao, S; Li, S,期刊:Cancer gene therapy, 页码:579-586 , 文章类型: Article,,卷期:2011年18-8]
- Established cell transfection via nucleofection relies on nucleofection buffers with unknown and proprietary makeup due to trade secrecy, inhibiting the possibility of using this otherwise effective method for developing...
- Enhanced specificity of HPV16 E6E7 siRNA by RNA-DNA chimera modification
[作者:Yamato, K; Egawa, N; Endo, S; Ui-Tei, K; Yamada, T; Saigo, K; Hyodo, I; Kiyono, T; Nakagawa, I,期刊:Cancer gene therapy, 页码:587-597 , 文章类型: Article,,卷期:2011年18-8]
- Although efforts have been made to develop new drugs for infectious and neoplastic diseases utilizing synthetic small interfering RNA(siRNAs), those intrinsically have undesirable effects, including silencing of unintend...
- Role of temperature-independent lipoplex-cell membrane interactions in the efficiency boost of multicomponent lipoplexes
[作者:Marchini, C; Pozzi, D; Montani, M; Alfonsi, C; Amici, A; De Sanctis, SC; Digman, MA; Sanchez, S; Gratton, E; Amenitsch, H; Fabbretti, A; Gualerzi, CO; Caracciolo, G,期刊:Cancer gene therapy, 页码:543-552 , 文章类型: Article,,卷期:2011年18-8]
- Multicomponent lipoplexes have recently emerged as especially promising transfection candidates, as they are from 10 to 100 times more efficient than binary complexes usually employed for gene delivery purposes. Previous...
- Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy
[作者:Schwenter, F; Zarei, S; Luy, P; Padrun, V; Bouche, N; Lee, JS; Mulligan, RC; Morel, P; Mach, N,期刊:Cancer gene therapy, 页码:553-562 , 文章类型: Article,,卷期:2011年18-8]
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjuvant in autologous cell-based anti-tumor immunotherapy has recently been approved for clinical application. To avoid the need for individualized process...
- Armed and targeted measles virus for chemovirotherapy of pancreatic cancer
[作者:Bossow, S; Grossardt, C; Temme, A; Leber, MF; Sawall, S; Rieber, EP; Cattaneo, R; von Kalle, C; Ungerechts, G,期刊:Cancer gene therapy, 页码:598-608 , 文章类型: Article,,卷期:2011年18-8]
- No curative therapy is currently available for locally advanced or metastatic pancreatic cancer. Therefore, new therapeutic approaches must be considered. Measles virus (MV) vaccine strains have shown promising oncolytic...
|